טוען...
Weekly paclitaxel as metronomic palliative chemotherapy in small cell lung cancer
BACKGROUND: Topotecan is the standard second line agent used in relapsed small cell lung cancer (SCLC). However, the erratic availability and the cost of the drug has been a prohibitive factor for its use in second-line setting in India. Paclitaxel has shown antitumor activity in heavily pretreated...
שמור ב:
| הוצא לאור ב: | South Asian J Cancer |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Medknow Publications & Media Pvt Ltd
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4873701/ https://ncbi.nlm.nih.gov/pubmed/27275452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.181643 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|